Celanese Corporation
NYSE:CEChemicals
-$0.24 today
- Market cap
- $5.29B
- Beta
- 0.74
- P/E (TTM)
- -5.1
- EPS (TTM)
- -$9.98
- Dividend yield
- 0.24%
Volume 1.38M
Average 2.09M
CE Operating Cash Flow
Cash generated by the company's core business operations during the period.
Celanese CorporationNYSE: CE
Operating Cash Flow · Q2 FY2026 · quarter ended Jun 2026
Operating cash flow declines year over year
Q2 FY2026 operating cash flow of $209M fell 49.0% year over year, behind the -3.5% change in trailing-twelve-month operating cash flow. Sequentially, it rose 175.0% from the prior quarter. Over 3 fiscal years it compounded at -14.3% a year.
Context
- Operating cash flow amounted to 12.0% of revenue in FY2025, up 2.6 pp from a year earlier.
- Operating cash flow increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -49.0% toward the trailing-twelve-month pace of -3.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 1.15B USD
- Year-over-year change
- +18.6%
- 4-year CAGR
- -10.1%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.15B | +18.6% |
| FY2024 | 2024-12-31 | 966M | -49.1% |
| FY2023 | 2023-12-31 | 1.9B | +4.4% |
| FY2022 | 2022-12-31 | 1.82B | +3.5% |
| FY2021 | 2021-12-31 | 1.76B | — |
Operating Cash Flow vs competitors
How CE compares with its peers on the latest reported figures
- Peers report in different currencies, so operating cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -3.5% is the 6th highest of 11, against a peer median of +0.4%.
- Operating cash flow amounts to 10.1% of revenue for CE, versus a peer median of 13.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2026 | ZAR 32.31B ZAR | -15.7% | -13.1% | 12.1% | |
| LTM Jun 2026 | $984M USD | -3.5% | -14.3% | 10.1% | |
| LTM Jun 2026 | $593.13M USD | +76.4% | +44.0% | 30.7% | |
| LTM Mar 2026 | $498.09M USD | -10.7% | +102.7% | 38.4% | |
| LTM Jun 2026 | $497M USD | -23.5% | +88.1% | 13.7% | |
| LTM Jun 2026 | $394M USD | +144.7% | — | 21.4% | |
| LTM Aug 2026 | $289.37M USD | +19.4% | +0.9% | 8.1% | |
| LTM Sep 2026 | $223.82M USD | +11.0% | +16.1% | 20.2% | |
| LTM Sep 2026 | $148.78M USD | +21.1% | +23.1% | 13.1% | |
| LTM Jun 2026 | $123.37M USD | -10.3% | +119.6% | 7.2% | |
| LTM Mar 2026 | $34.12M USD | -16.7% | -13.7% | — | |
| Peer median (excluding CE) | — | +0.4% | +23.1% | 13.7% | |
Competitors are the stored peer set for CE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.89B | 1.9B | 1.96B | (1.51B) | (1.14B) |
| Depreciation & Amortization | 378M | 478M | 711M | 823M | 786M |
| Deferred Income Tax | 13M | (835M) | (967M) | 216M | (278M) |
| Stock-Based Compensation | 95M | 60M | 40M | 32M | 0 |
| Change in Working Capital | (488M) | 280M | 516M | (204M) | 235M |
| Accounts Receivables | (396M) | 218M | 105M | 92M | 213M |
| Inventory | (367M) | (253M) | 398M | 11M | 154M |
| Accounts Payables | 353M | (84M) | 20M | (234M) | 26M |
| Other Working Capital | (78M) | 399M | (7M) | (73M) | (158M) |
| Other Non-Cash Items | (131M) | (66M) | (365M) | 1.61B | 1.55B |
| Operating Cash Flow | 1.76B | 1.82B | 1.9B | 966M | 1.15B |
| Capital Expenditures | (467M) | (543M) | (568M) | (435M) | (343M) |
| Acquisitions (Net) | (1.12B) | (10.54B) | 532M | 0 | 21M |
| Purchases of Investments | 467M | 0 | 0 | 0 | 0 |
| Sales of Investments | 516M | 0 | 0 | 17M | 0 |
| Other Investing Activities | (520M) | (57M) | (98M) | (52M) | (27M) |
| Investing Cash Flow | (1.12B) | (11.14B) | (134M) | (470M) | (349M) |
| Debt Repayment | 404M | 10.78B | (1.09B) | (948M) | (323M) |
| Common Stock Issued | 0 | 0 | 0 | 1M | 0 |
| Common Stock Repurchased | (1B) | (17M) | 0 | 0 | 0 |
| Dividends Paid | (304M) | (297M) | (305M) | (307M) | (13M) |
| Other Financing Activities | (142M) | (175M) | (63M) | (59M) | (177M) |
| Financing Cash Flow | (1.04B) | 10.29B | (1.46B) | (1.31B) | (513M) |
| Effect of Forex Changes | (15M) | 4M | (12M) | (26M) | 17M |
| Net Change in Cash | (419M) | 972M | 297M | (843M) | 301M |
| Free Cash Flow | 1.29B | 1.28B | 1.33B | 531M | 803M |
Celanese Corporation
NYSE:CE
Intrinsic Alpha fair value
Locked
Current Price
$48.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.